Brief: Island Pharmaceuticals Seeks Trading Halt
03/07/2026 03:24
BRIEF-Island Pharmaceuticals Seeks Trading Halt July 3 (Reuters) - Island Pharmaceuticals Ltd ILA.AX:
TRADING HALT PENDING ANNOUNCEMENT ON GALIDESIVIR USE IN EBOLA CLINICAL TRIAL IN AFRICA
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic